Streetbeat News

Regulatory

TSLA

Tesla Inc. (NASDAQ:TSLA) is in early discussions to license its self-driving technology to a major automaker. The potential partnership would involve integrating Tesla’s self-driving computer and camera system into the vehicles of the unnamed automaker. This development comes amid increasing scrutiny of Tesla’s Autopilot and Full Self-Driving features, which have been linked to 736 accidents and 17 fatalities in the U.S. since 2019.

Portfolio Pulse from Benzinga Neuro

July 20, 2023 | 2:33 am

DRUG

LSDI

PSIL

TRYPF

The House Rules Committee blocked all drug policy amendments to the National Defense Authorization Act (NDAA), preventing them from advancing to a floor vote. The American Psychedelic Practitioners Association (APPA) is working to legitimize the field of psychedelics. Bright Minds (NASDAQ:DRUG) consolidated its shares 5:1 to remain Nasdaq-listed, Lucy Scientific (NASDAQ:LSDI) appointed a new CEO, Tryp Therapeutics (OTC:TRYPF) received FDA approval for its Phase 2 psilocybin trial, and AdvisorShares Psychedelics ETF (NYSE:PSIL) maintained its opening price from the previous week.

Portfolio Pulse from Lara Goldstein

July 19, 2023 | 10:43 pm

SBT

Sterling Bancorp's plea agreement with the Department of Justice (DOJ) has received final court approval. The agreement, which resolves the DOJ's investigation into the bank's Advantage Loan Program, requires the company to pay $27.2 million in restitution to non-insider victim shareholders.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 10:05 pm

VGK

WEAT

The White House has warned that Russia may expand its targeting of Ukrainian grain facilities to include attacks against civilian shipping in the Black Sea. This could potentially disrupt grain exports from the region.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:54 pm

AIR

AAR Corp has received approval from Miami-Dade County for the expansion of its Miami Airframe MRO facility. The company plans to start construction in Q2 of FY2024 and complete it within 24 months. The county is expected to reimburse the $50 million construction cost over time. This will increase the capacity of AAR's Miami Airframe MRO by 33%.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 9:50 pm

PFE

Pfizer has reported results from an ongoing Phase 2 study on its Group B Streptococcus (GBS) maternal vaccine candidate, GBS6. The study, published in the New England Journal of Medicine, showed that the vaccine was well-tolerated and generated robust maternal antibody responses that were efficiently transferred to infants. The safety profile was similar between the vaccine and placebo groups in both mothers and infants.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 9:25 pm

ALNY

Alnylam Pharmaceuticals has reported the publication of Phase 1 study results for Zilebesiran in the New England Journal of Medicine. The data showed that Zilebesiran was associated with dose-dependent reductions in serum AGT, achieving tonic blood pressure control with consistent and durable blood pressure reduction throughout a 24-hour period, sustained up to six months after single doses of ≥200 mg.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 9:01 pm

ATVI

MSFT

Microsoft and Activision have filed a motion to the U.S. Federal Trade Commission asking for the case against Activision's acquisition to be withdrawn, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 8:30 pm

NBTX

Nanobiotix has announced the first patient injection in a new Phase 1/2 study evaluating the combination of radiotherapy-activated NBTXR3 and anti-PD-1 for patients with advanced cancers.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 8:16 pm

SPY

President Biden has emphasized the need to continue making progress on inflation. No specific measures or strategies were mentioned in the article.

Portfolio Pulse from Happy Mohamed

July 19, 2023 | 7:32 pm